Abstract:Background/Aims: The purpose of this study was to probe the clinico-pathological significance and the underlying mechanism of miR-30d-5p expression in non-small cell lung cancer (NSCLC). Methods: We initially examined the level of miR-30d-5p expression in NSCLC and non-cancer tissues using RT-qPCR. Then, a series of validation analyses including a meta-analysis of data from microarray chips in Gene Expression Omnibus (GEO), data mining of the cancer genome atlas (TCGA) and an integrated meta-analysis incorporating GEO microarray chips, TCGA data, in-house RT-qPCR and literature studies were performed to examine the clinico-pathological value of miR-30d-5p expression in NSCLC. In vitro experiments were further conducted to investigate the impact of miR-30d-5p on NSCLC cell growth. The molecular mechanism by which miR-30d-5p regulates the pathogenesis of NSCLC was probed through a bioinformatics analysis of its target genes. Moreover, dual luciferase reporter assay was conducted to verify the targeting regulatory relationship between miR-30d-5p and CCNE2. Results: Based on results from RT-qPCR, GEO meta-analysis, TCGA data mining and the integrated meta-analysis incorporating GEO microarray chips, TCGA data, in-house RT-qPCR and literature studies, miR-30d-5p expression was decreased in NSCLC tissues, and patients with NSCLC who presented with lower miR-30d-5p expression tended to display an advanced clinical progression. Significant pathways including the Mucin type O-glycan biosynthesis pathway, cell cycle pathway and cysteine and methionine metabolism pathway (all P< 0.05) revealed potential roles of the target genes of miR-30d-5p in the oncogenesis of NSCLC. Results from in vitro experiments indicated that miR-30d-5p could attenuate proliferation and viability of NSCLC cells. Among the 12 identified hub genes, nine genes including E2F3, CCNE2, SKP2, CDK6, TFDP1, LDHA, GOT2, DNMT3B and ST6GALNAC1 were validated by Pearson’s correlation test and the human protein atlas (HPA) database as targets of miR-30d-5p with higher probability. Specifically, dual luciferase reporter assay confirmed that CCNE2 was directly targeted by miR-30d-5p. Conclusion: In summary, miR-30d-5p expression is decreased in NSCLC, and it might play the role as tumor suppressor in NSCLC by regulating target genes.

Mir-382 Inhibits Tumor Progression by Targeting SETD8 in Non-Small Cell Lung Cancer.

MiR-502/SET8 regulatory circuit in pathobiology of breast cancer.

MiR-502/SET8 Regulatory Circuit in Pathobiology of Breast Cancer

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

Retraction Note: Dual Roles of Mir-374A by Modulated C-Jun Respectively Targets CCND1-inducing PI3K/AKT Signal and PTEN-suppressing Wnt/β-catenin Signaling in Non-Small-cell Lung Cancer.

MiR-3188 Inhibits Non-small Cell Lung Cancer Cell Proliferation Through FOXO1-Mediated mTOR-p-PI3K/AKT-c-JUN Signaling Pathway

Data from Downregulation of DNMT3A by Mir-708-5p Inhibits Lung Cancer Stem Cell–like Phenotypes Through Repressing Wnt/β-catenin Signaling

Mir-375 Inhibits the Invasion and Metastasis of Colorectal Cancer Via Targeting SP1 and Regulating EMT-associated Genes.

Expression Signature and Role of Mir-30D-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments

microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.

Downregulation of Mir‐3127‐5p Promotes Epithelial‐mesenchymal Transition Via FZD4 Regulation of Wnt/β‐catenin Signaling in Non‐small‐cell Lung Cancer

CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis

MicroRNA-30d-5p Inhibits Tumour Cell Proliferation and Motility by Directly Targeting CCNE2 in Non-Small Cell Lung Cancer.

MiR-383-5p inhibits the proliferation and migration of lung adenocarcinoma cells by targeting SHMT2

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

Mir-4746 inhibits the proliferation of colorectal cancer cells in vitro and in vivo by targeting CCND1